학술논문
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
Document Type
Article
Author
Source
In: Leukemia Research . (Leukemia Research, May 2024, 140)
Subject
Language
English
ISSN
18735835
01452126
01452126